Cervical cancer
This page displays all content tagged with this topic. If you're looking for more specific information, please use the search page for advanced filtering.
Cameroon’s people-centred HPV vaccination campaign builds trust through mothers, churches, and community health workers
Podcast "Let's Talk Cancer" – Providing supportive care in Egypt
Cervical cancer remains a leading cause of cancer-related mortality among women in low- and middle-income countries. Effective treatment of precancerous lesions detected during cervical screening is critical to reduce the incidence of cervical cancer.
Every year cervical cancer kills nearly 350 000 women globally, 90% of whom live in low- and middle-income countries (LMICs). More than 95% of cervical cancers are caused by oncogenic types of human papillomavirus (HPV).
This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendations and 7 good practice statements.
Nigeria's path to cervical cancer elimination: Challenges, data, and people-centred care
In 2025, the World Health Organization released the World Cervical Cancer Elimination Day 2025 toolkit.
Online course: The Cervical Cancer Elimination Initiative foundational course
Global resolve for cervical cancer elimination: insights from the second Forum in Bali
